Abstract
The structure–activity relationships for small molecule antagonists of the Malignant Brain Tumor (MBT) domain family of methyl-lysine readers are described and activity demonstrated in histone peptide pull-down assays.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have